G Medical Innovations Holdings Ltd
GMVD · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $4 | $5 | $5 | $6 |
| % Growth | -12.6% | 3.2% | -11.3% | – |
| Cost of Goods Sold | $4 | $4 | $4 | $6 |
| Gross Profit | $1 | $2 | $1 | -$0 |
| % Margin | 17.7% | 29.7% | 13.6% | -4% |
| R&D Expenses | $2 | $2 | $1 | $3 |
| G&A Expenses | $25 | $9 | $8 | $10 |
| SG&A Expenses | $25 | $9 | $8 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $1 | $4 | $0 |
| Operating Expenses | $28 | $12 | $13 | $13 |
| Operating Income | -$27 | -$10 | -$12 | -$15 |
| % Margin | -620.1% | -198.4% | -245% | -262.9% |
| Other Income/Exp. Net | $13 | -$4 | -$1 | -$4 |
| Pre-Tax Income | -$14 | -$15 | -$13 | -$16 |
| Tax Expense | $0 | -$0 | -$0 | -$1 |
| Net Income | -$14 | -$15 | -$13 | -$16 |
| % Margin | -315.8% | -294.3% | -258.9% | -280.6% |
| EPS | 0 | -45.89 | -60.4 | -7 |
| % Growth | 100% | 24% | -762.9% | – |
| EPS Diluted | 0 | -45.89 | -60.4 | -7 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 2 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $0 |
| Interest Expense | $0 | $4 | $1 | $4 |
| Depreciation & Amortization | -$10 | $1 | $4 | $2 |
| EBITDA | -$38 | -$9 | -$8 | -$13 |
| % Margin | -854.1% | -178.7% | -171.4% | -226.5% |